SEC Form 4 · accession 0001562180-17-001253
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Douglas Altstiel
Officer — Chief Medical Officer
Period of report
Mar 10, 2017
Accepted (ET)
Mar 14, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $5.81 | Mar 10, 2017 | A | 128,085 | A | — | Mar 10, 2027 | Class A Common Stock | 128,085 | 268,085 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning March 10, 2018